Bare-metal stents are a valid alternative to drug eluting stents, but are no longer considered to be state of the art.Load more
Bare-metal stents are a valid alternative to drug eluting stents, but are no longer considered to be state of the art.
One of the advantages of bare-metal stents is that these devices show vascular healing after 4–6 months with almost 100% re-endothelialisation. Late and very late stent thrombosis are rare events, seen only in patients with delayed healing or those whoa re allergic to nickel and chromium. Bare-metal stents are easy to implant, with a small profile and good trackability.
The major disadvantage of the bare-metal stent is that it is associated with restenosis rates from 15–20% and re-intervention will be required in 5–10% of cases. However, dual antiplatelet therapy is needed only for 1–2 months.Load Less
Michael Lee, Jeremy KongInterventional Cardiology Review 2017;12(2):85–91.DOI: https://doi.org/10.15420/icr.2017:4:2
Serban BalanescuEuropean Cardiology Review 2016;11(2):77–82DOI: https://doi.org/10.15420/ecr/2016:24:2
John Rawlins, Jehangir Din, Suneel Talwar, et alInterventional Cardiology Review 2015;10(2):85–9DOI: https://doi.org/10.15420/icr.2015.10.2.85
Rebecca L Noad, Colm G Hanratty, Simon J Walsh, et alInterventional Cardiology Review 2014;9(2):89-93DOI: https://doi.org/10.15420/articles/clinical-impact-stent-design